The ASBMB’s Public Affairs Department encourages all readers of the Policy Blotter to alert the office about interesting and relevant articles. Please send tips to firstname.lastname@example.org..
What’s new in Blotter news?
ASBMB’s education and professional development manager, Erica Siebrasse, discusses the ASBMB’s recommendations to the National Institute of General Medical Sciences on how to “catalyze the modernization of graduate education.”
During the International Regenerative Medicine Conference, held by the Vatican in April 2016, scientists from around the world discussed biomedical advancements and how embryonic stem cells can be used to treat a multitude of diseases. Despite continued advancements and innovations in stem cell technologies, religious, cultural and government resistance has all but prevented the domestic use of stem cell therapies in the U.S. As medicine continues to evolve, the scientific community urges lawmakers to invest in stem cell technologies to treat disease.
The new age of medicine (Worth)
The White House announced plans to hold a conference on technological innovation in Pittsburgh in October. The White House Frontiers Conference will focus on expanding U.S. capacity in the fields of science and technology that will “continue to shape the 21st century and beyond.”
Obama to host tech conference in Pittsburgh (The Hill)
President Obama is urging Congress to make passing emergency funds for Zika research its first priority when lawmakers resume work after the Labor Day weekend. While Congress continues to fight over appropriations, officials from the CDC and NIH say that current Zika research funds are close to being exhausted. Centers for Disease Control and Prevention and National Institutes of Health officials insist that how Congress is handling Zika is a prime example of how not to combat future health pandemics. Despite these funding concerns, a collaboration study between the NIH, Johns Hopkins University and Florida State University has identified a number of current Food and Drug Administration-approved medications that could serve as potential Zika therapies.
U.S. funding for fighting Zika virus is nearly spent, CDC says (New York Times)